Nyhende- og debattavisa for unge – Framtida.no er ei redaksjonelt uavhengig avis, som har som mål å styrkja nynorsken og ...
UCB has been bringing up the rear in the IL-17 inhibitor category with bimekizumab, but now has EU approval for the drug and thinks it can mount a stiff challenge to the leaders, including ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...
ETSI ISG ZSM-(24)000095-LS11 - [https://www.itu.int/ifa/t/2022/ls/etsiisgzsm/sp17-etsiisgzsm-iLS-00011.docx] ...
VAR offsides could reportedly be banned from Euro 2024 due to UEFA being taken to court on the eve of the tournament. This summer's tournament is set to get underway on June 14, with England's ...
Belgian biopharma company UCB is bringing up the rear of the IL-17 inhibitor category with its bimekizumab drug, so is celebrating new late-stage data showing superiority to the class leader.
The interleukin-17 (IL-17) family cytokines are strong inducers of inflammation and help to protect us against invading pathogens. However, they also have a dark side and contribute to the tissue ...
Be ready to be impressed by the unique high Alpine lakes and flora of the Upper Engadin on this 2.5-hour circular hike to the six ...
Elysa (Self)Brigitte (Self)Virma (Self)Lucienne (Self)Gérard (Self)Corine (Self)Caline (Self)Eva (Self)Josée (Self)Marie-Christine Guennec (Evelyne) Michel Ricaud A look on transvestites and ...
Stefan de Vylder (Self)Mikael Nyberg (Self)Kent Werne (Self)Jan Öhman (Self) Gunnar Lindholm The Swedish society, once world-famous for its economical agalitarity has had its down-build due to ...